Syntax Bio, a synthetic biology company programming the next generation of cell therapies, today announced the publication of ...

Syntax Bio, a synthetic biology company programming the next generation of cell therapies, today announced the publication of ...

Syntax Bio, a synthetic biology company programming the next generation of cell therapies, has published new research in ...

Revvity targets 2026 growth with multiomics, AI-powered base editing, NGS newborn screening, and immunotherapy advances.

Syntax Bio, a synthetic biology company programming the next generation of cell therapies, today announced the publication of ...

For years, Yale researchers David Breslow and Mustafa Khokha have worked together with a similar challenge in their ...

CRISPR Therapeutics shows improving price performance, earning an upgrade to its IBD Relative Strength Rating from 71 to 82.

NLP Logix, one of the fastest-growing artificial intelligence consultancies in the United States, announced the appointment of D.J. Price as its new Chief Revenue Officer (CRO). Price brings more than ...

Altair, a global leader in computational intelligence and now part of leading technology company, Siemens, announced the latest updates to HyperWorks® 2026 software. With significant advances in AI, ...

This live blog is refreshed periodically throughout the day with the latest updates from the market.To find the latest Stock Market Today threads, click here. Happy Tuesday. This is TheStreet’s Stock ...

For years Yale researchers David Breslow and Mustafa Khokha have worked together with a similar challenge in their sights - trying to capture the ...

Industrialized, small batch, and individual RNA therapeutics become practical with “in-a-box” manufacturing technology.